Overview
Ronald Weinger is an Oncologist and a Hematologist in Peabody, Massachusetts. Dr. Weinger is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Polycythemia Vera, Non-Hodgkin Lymphoma, Essential Thrombocythemia, and Myelodysplastic Syndrome (MDS).
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute, Inc.
David Reardon is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Reardon is rated as an Elite provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Tissue Biopsy. Dr. Reardon is currently accepting new patients.
The General Hospital Corporation
Priscilla Brastianos is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Brastianos is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Brain Tumor, Metastatic Brain Tumor, Melanoma, and Posterior Fossa Tumor.
Dana-Farber Cancer Institute, Inc.
Michael Rabin is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Rabin is rated as an Elite provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Rabin is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Immune ThrombocytopeniaDr. Weinger isDistinguished. Learn about Adult Immune Thrombocytopenia.
- B-Cell LymphomaDr. Weinger isDistinguished. Learn about B-Cell Lymphoma.
- Chronic Lymphocytic Leukemia (CLL)Dr. Weinger isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelomonocytic Leukemia (CMML)Dr. Weinger isDistinguished. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Essential ThrombocythemiaDr. Weinger isDistinguished. Learn about Essential Thrombocythemia.
- Hemangioma Thrombocytopenia SyndromeDr. Weinger isDistinguished. Learn about Hemangioma Thrombocytopenia Syndrome.
- Advanced
- AnemiaDr. Weinger isAdvanced. Learn about Anemia.
- Autoimmune Hemolytic AnemiaDr. Weinger isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Weinger isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Classical Hodgkin LymphomaDr. Weinger isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Familial Prostate CancerDr. Weinger isAdvanced. Learn about Familial Prostate Cancer.
- Experienced
- Acquired AgranulocytosisDr. Weinger isExperienced. Learn about Acquired Agranulocytosis.
- Acute Eosinophilic PneumoniaDr. Weinger isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Weinger isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Weinger isExperienced. Learn about Acute Myelomonocytic Leukemia.